|
US2020108082A1
|
|
Methods and compositions for treating diseases related to imbalance of essential fatty acids
|
|
US2017319607A1
|
|
Methods and compositions for treating symptoms of diseases related to imbalance of essential fatty acids
|
|
US2015265637A1
|
|
Methods and compositions for treating symptoms of diseases related to imbalance of essential fatty acids
|
|
WO2015142500A2
|
|
Compositions and methods for treating addiction
|
|
US2010022444A1
|
|
Combination therapy for modulation of activity and development of cells and tissues
|
|
US2008145506A1
|
|
Food compositions and products containing balanced ratio of essential fatty acids
|
|
US2008254017A1
|
|
Methods and compositions for treating symptomes of diseases related to imbalance of essential fatty acids
|
|
US2007248542A1
|
|
Devices and methods for individualized detection of nutrient imbalance via olfactory system
|
|
US2007042008A1
|
|
Compositions containing phosphatidylcholine and essential fatty acids
|
|
US2007004639A1
|
|
Methods and compositions for treating Parkinson's disease
|
|
EP1733345A2
|
|
Network and methods for integrating individualized clinical test results and nutritional treatment
|
|
US2005019423A1
|
|
Method for treating amyotrophic lateral sclerosis
|
